Cargando…

Recent effectiveness of proton pump inhibitors for severe reflux esophagitis: the first multicenter prospective study in Japan

Proton pump inhibitors are the first-line treatment for reflux esophagitis. Because severe reflux esophagitis has very low prevalence in Japan, little is known about the effectiveness of proton pump inhibitors in these patients. This prospective multicenter study assessed the effectiveness of proton...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizuno, Hideki, Matsuhashi, Nobuyuki, Sakaguchi, Masahiro, Inoue, Syuji, Nakada, Koji, Higuchi, Kazuhide, Haruma, Ken, Joh, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	the Society for Free Radical Research Japan 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4639585/ https://www.ncbi.nlm.nih.gov/pubmed/26566310 http://dx.doi.org/10.3164/jcbn.14-144

Ejemplares similares

Clinical features and therapeutic responses to proton pump inhibitor in patients with severe reflux esophagitis: A multicenter prospective observational study
por: Isshi, Kimio, et al.
Publicado: (2020)

Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms
por: Nakada, Koji, et al.
Publicado: (2017)

Clinical significance of gastroesophageal reflux disease with minimal change: a multicenter prospective observational study
por: Manabe, Noriaki, et al.
Publicado: (2022)

Sex differences in risk factors for future onset of reflux esophagitis
por: Osaga, Satoshi, et al.
Publicado: (2021)

Comparison of the effects of individual symptoms of gastroesophageal reflux disease co‐existing functional dyspepsia on patients' daily lives: A prospective, observational study
por: Nakada, Tatsuya, et al.
Publicado: (2022)

Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors
por: Mizuno, Hideki, et al.
Publicado: (2018)

Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
por: Asaoka, Daisuke, et al.
Publicado: (2019)

Factors associated with complicated erosive esophagitis: A Japanese multicenter, prospective, cross-sectional study
por: Sakaguchi, Masahiro, et al.
Publicado: (2017)

Trends in proton pump inhibitor use, reflux esophagitis, and various upper gastrointestinal symptoms from 2010 to 2019 in Japan
por: Yamamichi, Nobutake, et al.
Publicado: (2022)

The daily response for proton pump inhibitor treatment in Japanese reflux esophagitis and non-erosive reflux disease
por: Shida, Hiroshi, et al.
Publicado: (2013)

Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease
por: Gotoh, Yasuhiko, et al.
Publicado: (2020)

Efficacy and Safety Profile of Z-215 (Azeloprazole Sodium), a Proton Pump Inhibitor, Compared with Rabeprazole Sodium in Patients with Reflux Esophagitis: A Phase II, Multicenter, Randomized, Double-Blind, Comparative Study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2018)

Upper Esophageal Sphincter Compression Device as an Adjunct to Proton Pump Inhibition for Laryngopharyngeal Reflux
por: Yadlapati, Rena, et al.
Publicado: (2021)

Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors
por: Gerson, Lauren B, et al.
Publicado: (2008)

Predictive Factors for Future Onset of Reflux Esophagitis: A Longitudinal Case-control Study Using Health Checkup Records
por: Toki, Yuzuru, et al.
Publicado: (2022)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Eosinophilic esophagitis in patients with typical gastroesophageal reflux disease symptoms refractory to proton pump inhibitor
por: de Sá, Cláudia Cristina, et al.
Publicado: (2011)

Can Esophageal Baseline Impedance Predict Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease?
por: Jung, Kyoungwon, et al.
Publicado: (2018)

Cost-effectiveness analysis of vonoprazan versus proton pump inhibitors in the treatment of reflux esophagitis in China
por: Wang, Zhenhua, et al.
Publicado: (2022)

Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito
por: Sakata, Yasuhisa, et al.
Publicado: (2014)

A Study on the Efficacy of Proton Pump Inhibitors in Helicobacter pylori-Negative Primary Care Patients with Dyspepsia in Japan
por: Kamada, Tomoari, et al.
Publicado: (2013)

Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole
por: Mermelstein, Joseph, et al.
Publicado: (2016)

Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
por: Kuipers, E. J., et al.
Publicado: (1999)

Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study
por: Kinoshita, Yoshikazu, et al.
Publicado: (2017)

Complete Resolution of Pseudomalignant Erosion in a Reflux Gastroesophageal Polyp with Proton Pump Inhibitor
por: Nakajima, Takahiko, et al.
Publicado: (2015)

Crystal structure of schizorhodopsin reveals mechanism of inward proton pumping
por: Higuchi, Akimitsu, et al.
Publicado: (2021)

Clinical value of wireless pH-monitoring of gastro-esophageal reflux in children before and after proton pump inhibitors
por: Boström, Michaela, et al.
Publicado: (2014)

Role of altered esophageal intraluminal baseline impedance levels in patients with gatroesophageal reflux disease refractory to proton pump inhibitors
por: Jiang, Liuqin, et al.
Publicado: (2016)

Esophageal Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index in Identifying Proton Pump Inhibitor-refractory Non-erosive Reflux Disease
por: Wang, Yan, et al.
Publicado: (2021)

Role of Acid and Weakly Acidic Reflux in Gastroesophageal Reflux Disease Off Proton Pump Inhibitor Therapy
por: Sung, Hea Jung, et al.
Publicado: (2012)

Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions
por: Mermelstein, Joseph, et al.
Publicado: (2018)

Effects of Proton Pump Inhibitors on the Gastrointestinal Microbiota in Gastroesophageal Reflux Disease
por: Shi, Yi-Chao, et al.
Publicado: (2019)

Meta-analysis of the efficacy of proton pump inhibitors for the symptoms of laryngopharyngeal reflux
por: Liu, C., et al.
Publicado: (2016)

Meta-analysis of Proton Pump Inhibitors in the Treatment of Pharyngeal Reflux Disease
por: Jin, Xiulin, et al.
Publicado: (2022)

Background Factors of Reflux Esophagitis and Non-Erosive Reflux Disease: A Cross-Sectional Study of 10,837 Subjects in Japan
por: Minatsuki, Chihiro, et al.
Publicado: (2013)

Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study
por: Inoue, Haruhiro, et al.
Publicado: (2020)

Is a proton-pump inhibitor necessary after endoscopic submucosal dissection for superficial esophageal neoplasms? A propensity score analysis
por: Kanaoka, Hideaki, et al.
Publicado: (2020)

Efficacy of Vonoprazan for Gastroesophageal Reflux Symptoms in Patients with Proton Pump Inhibitor-resistant Non-erosive Reflux Disease
por: Niikura, Ryota, et al.
Publicado: (2018)

Eosinophilic Esophagitis on and off Proton Pump Inhibitor
por: Zimmer, Vincent, et al.
Publicado: (2023)

Is It Useful to Administer Probiotics Together With Proton Pump Inhibitors in Children With Gastroesophageal Reflux?
por: Belei, Oana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_80u01uastqmjjg5fpijno68bui